Cargando…

Effect of iron content on the tolerability of prenatal multivitamins in pregnancy

BACKGROUND: Gastrointestinal irritability can deter pregnant women from starting or continuing prenatal multivitamin supplementation. In a previous study, suboptimal tolerability was observed among pregnant women taking a large tablet (18 mm × 8 mm × 8 mm) multivitamin with high elemental iron conte...

Descripción completa

Detalles Bibliográficos
Autores principales: Nguyen, Patricia, Nava-Ocampo, Alejandro, Levy, Amalia, O'Connor, Deborah L, Einarson, Tom R, Taddio, Anna, Koren, Gideon
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2405769/
https://www.ncbi.nlm.nih.gov/pubmed/18482454
http://dx.doi.org/10.1186/1471-2393-8-17
_version_ 1782155647728484352
author Nguyen, Patricia
Nava-Ocampo, Alejandro
Levy, Amalia
O'Connor, Deborah L
Einarson, Tom R
Taddio, Anna
Koren, Gideon
author_facet Nguyen, Patricia
Nava-Ocampo, Alejandro
Levy, Amalia
O'Connor, Deborah L
Einarson, Tom R
Taddio, Anna
Koren, Gideon
author_sort Nguyen, Patricia
collection PubMed
description BACKGROUND: Gastrointestinal irritability can deter pregnant women from starting or continuing prenatal multivitamin supplementation. In a previous study, suboptimal tolerability was observed among pregnant women taking a large tablet (18 mm × 8 mm × 8 mm) multivitamin with high elemental iron content (60 mg as ferrous fumarate). The objective of the present study was to compare rates of adherence and reported adverse events among pregnant women who were randomized to commence supplementation with a small-tablet prenatal multivitamin, containing either low or high iron content. METHODS: Pregnant women who called the Motherisk Program (Hospital for Sick Children, Toronto) and had not started taking or had discontinued any multivitamin due to adverse events were included in this prospective, randomized, open-label, 2-arm study. Women were randomized to take a small-size (16 mm × 9 mm × 4 mm), low elemental iron content (35 mg as ferrous fumarate) multivitamin ('35 mg' group); or a small-size (5 mm radius, 5 mm thickness), high elemental iron content (60 mg as ferrous sulphate) multivitamin ('60 mg' group). Follow-up interviews documented pill intake and adverse events. Rates of adherence and adverse events were compared between groups using chi-squared tests and Kaplan-Meier survival curves. RESULTS: Of 167 randomized women, 92 in the '35 mg' group and 75 in the '60 mg' group were included in the analysis. Despite ideal conditions and regular follow-ups, mean adherence based on pill intake recall, in both groups was approximately 50%. No statistically significant difference was detected in proportions of women who actually started taking either multivitamin. Among those who started, no difference was detected in rates of adherence or reported adverse events. CONCLUSION: The present results suggest that iron content is not a major determinant of adherence to prenatal multivitamins. Combined with our previous study, tablet size may be the more definitive factor affecting adherence.
format Text
id pubmed-2405769
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-24057692008-05-30 Effect of iron content on the tolerability of prenatal multivitamins in pregnancy Nguyen, Patricia Nava-Ocampo, Alejandro Levy, Amalia O'Connor, Deborah L Einarson, Tom R Taddio, Anna Koren, Gideon BMC Pregnancy Childbirth Research Article BACKGROUND: Gastrointestinal irritability can deter pregnant women from starting or continuing prenatal multivitamin supplementation. In a previous study, suboptimal tolerability was observed among pregnant women taking a large tablet (18 mm × 8 mm × 8 mm) multivitamin with high elemental iron content (60 mg as ferrous fumarate). The objective of the present study was to compare rates of adherence and reported adverse events among pregnant women who were randomized to commence supplementation with a small-tablet prenatal multivitamin, containing either low or high iron content. METHODS: Pregnant women who called the Motherisk Program (Hospital for Sick Children, Toronto) and had not started taking or had discontinued any multivitamin due to adverse events were included in this prospective, randomized, open-label, 2-arm study. Women were randomized to take a small-size (16 mm × 9 mm × 4 mm), low elemental iron content (35 mg as ferrous fumarate) multivitamin ('35 mg' group); or a small-size (5 mm radius, 5 mm thickness), high elemental iron content (60 mg as ferrous sulphate) multivitamin ('60 mg' group). Follow-up interviews documented pill intake and adverse events. Rates of adherence and adverse events were compared between groups using chi-squared tests and Kaplan-Meier survival curves. RESULTS: Of 167 randomized women, 92 in the '35 mg' group and 75 in the '60 mg' group were included in the analysis. Despite ideal conditions and regular follow-ups, mean adherence based on pill intake recall, in both groups was approximately 50%. No statistically significant difference was detected in proportions of women who actually started taking either multivitamin. Among those who started, no difference was detected in rates of adherence or reported adverse events. CONCLUSION: The present results suggest that iron content is not a major determinant of adherence to prenatal multivitamins. Combined with our previous study, tablet size may be the more definitive factor affecting adherence. BioMed Central 2008-05-15 /pmc/articles/PMC2405769/ /pubmed/18482454 http://dx.doi.org/10.1186/1471-2393-8-17 Text en Copyright © 2008 Nguyen et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Nguyen, Patricia
Nava-Ocampo, Alejandro
Levy, Amalia
O'Connor, Deborah L
Einarson, Tom R
Taddio, Anna
Koren, Gideon
Effect of iron content on the tolerability of prenatal multivitamins in pregnancy
title Effect of iron content on the tolerability of prenatal multivitamins in pregnancy
title_full Effect of iron content on the tolerability of prenatal multivitamins in pregnancy
title_fullStr Effect of iron content on the tolerability of prenatal multivitamins in pregnancy
title_full_unstemmed Effect of iron content on the tolerability of prenatal multivitamins in pregnancy
title_short Effect of iron content on the tolerability of prenatal multivitamins in pregnancy
title_sort effect of iron content on the tolerability of prenatal multivitamins in pregnancy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2405769/
https://www.ncbi.nlm.nih.gov/pubmed/18482454
http://dx.doi.org/10.1186/1471-2393-8-17
work_keys_str_mv AT nguyenpatricia effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy
AT navaocampoalejandro effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy
AT levyamalia effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy
AT oconnordeborahl effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy
AT einarsontomr effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy
AT taddioanna effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy
AT korengideon effectofironcontentonthetolerabilityofprenatalmultivitaminsinpregnancy